{
  "data_from_source": [
    {
      "assignees": [
        "RapidDx Genomics"
      ],
      "authors": [],
      "country": "United States",
      "cpcs": [
        "C12Q1/6806",
        "G16B30/00",
        "G16H50/70"
      ],
      "data_quality_score": 0.88,
      "domain": "Healthcare",
      "id": "patents_BT-PAT-020",
      "inventors": [
        "Schatz, Michael C.",
        "Phillippy, Adam M.",
        "Zimin, Aleksey V."
      ],
      "ipcs": [
        "C12Q1/6806",
        "G16B30/00",
        "G16H50/70"
      ],
      "keywords": [
        "metagenomic",
        "pathogen detection",
        "antimicrobial resistance",
        "nanopore sequencing"
      ],
      "knowledge_type": "patent",
      "publication_date": "2023-05-04",
      "publishers": [],
      "related_titles": [
        "Method for mRNA Delivery Using Lipid Nanoparticles",
        "CRISPR-Cas9 System for Targeted Gene Editing",
        "Bispecific Antibodies Targeting PD-1 and CTLA-4",
        "Engineered CAR-T Cells with Enhanced Tumor Targeting",
        "Microbiome-Based Therapeutics for Inflammatory Bowel Disease",
        "Scalable Process for Manufacturing Exosome Therapeutics",
        "Synthetic Biology Platform for On-Demand Therapeutic Protein Production",
        "AI-Based Platform for De Novo Protein Design",
        "Biodegradable Scaffolds for 3D Bioprinting of Functional Tissues",
        "High-Throughput Screening Platform for Antibody Discovery",
        "Engineered Bacterial Strains for Targeted Colorectal Cancer Therapy",
        "RNA-Based Vaccine Platform for Infectious Diseases",
        "Organs-on-Chips for Drug Toxicity Testing",
        "Machine Learning Platform for Predicting Drug-Target Interactions",
        "Nanobody Therapeutics for Neurodegenerative Diseases",
        "Gene Therapy for Age-Related Macular Degeneration",
        "Continuous Manufacturing Process for mRNA Vaccines",
        "PROTAC Technology for Protein Degradation",
        "Single-Cell Multi-omics Analysis of the Immune Response in COVID-19",
        "CRISPR-Engineered T Cells in Patients with Refractory Cancer",
        "Spatial Transcriptomics Reveals Insights into the Tumor Microenvironment",
        "In Vivo Base Editing Corrects Hutchinson–Gilford Progeria Syndrome in Mice",
        "Engineered Living Materials: Prospects and Challenges for Using Biological Systems to Direct the Assembly of Smart Materials",
        "Intestinal Organoids as a Tool for Inflammatory Bowel Disease Research",
        "Enzyme-Free Biosensor for Continuous Glucose Monitoring",
        "Microbiome-Based Therapeutics Shape the Gut Microbiome and Improve Metabolic Syndrome",
        "Massively Parallel Screening of Protein Design Space Using Machine Learning",
        "PROTAC Degraders for Previously Undruggable Transcription Factors in Cancer"
      ],
      "similarity_score": 0.6646566390991211,
      "subdomains": [
        "Biotech",
        "Diagnostics"
      ],
      "summary_text": "No summary available",
      "technologies": [
        "metagenomic sequencing",
        "nanopore technology",
        "bioinformatics"
      ],
      "title": "Real-Time Pathogen Detection System Using Metagenomic Sequencing"
    },
    {
      "assignees": [
        "RapidVax Inc."
      ],
      "authors": [],
      "country": "United States",
      "cpcs": [
        "C12N15/88",
        "A61K39/00",
        "A61K47/69"
      ],
      "data_quality_score": 0.93,
      "domain": "Healthcare",
      "id": "patents_BT-PAT-012",
      "inventors": [
        "Karikó, Katalin",
        "Weissman, Drew",
        "Pardi, Norbert"
      ],
      "ipcs": [
        "C12N15/88",
        "A61K39/00",
        "A61K47/69"
      ],
      "keywords": [
        "mRNA",
        "vaccine",
        "infectious disease",
        "lipid nanoparticle"
      ],
      "knowledge_type": "patent",
      "publication_date": "2019-09-05",
      "publishers": [],
      "related_titles": [
        "Method for mRNA Delivery Using Lipid Nanoparticles",
        "CRISPR-Cas9 System for Targeted Gene Editing",
        "Bispecific Antibodies Targeting PD-1 and CTLA-4",
        "Engineered CAR-T Cells with Enhanced Tumor Targeting",
        "Microbiome-Based Therapeutics for Inflammatory Bowel Disease",
        "Scalable Process for Manufacturing Exosome Therapeutics",
        "Synthetic Biology Platform for On-Demand Therapeutic Protein Production",
        "AI-Based Platform for De Novo Protein Design",
        "Biodegradable Scaffolds for 3D Bioprinting of Functional Tissues",
        "High-Throughput Screening Platform for Antibody Discovery",
        "Engineered Bacterial Strains for Targeted Colorectal Cancer Therapy",
        "Organs-on-Chips for Drug Toxicity Testing",
        "Machine Learning Platform for Predicting Drug-Target Interactions",
        "Nanobody Therapeutics for Neurodegenerative Diseases",
        "Gene Therapy for Age-Related Macular Degeneration",
        "Continuous Manufacturing Process for mRNA Vaccines",
        "PROTAC Technology for Protein Degradation",
        "Real-Time Pathogen Detection System Using Metagenomic Sequencing",
        "Single-Cell Multi-omics Analysis of the Immune Response in COVID-19",
        "CRISPR-Engineered T Cells in Patients with Refractory Cancer",
        "Spatial Transcriptomics Reveals Insights into the Tumor Microenvironment",
        "In Vivo Base Editing Corrects Hutchinson–Gilford Progeria Syndrome in Mice",
        "Engineered Living Materials: Prospects and Challenges for Using Biological Systems to Direct the Assembly of Smart Materials",
        "Intestinal Organoids as a Tool for Inflammatory Bowel Disease Research",
        "Enzyme-Free Biosensor for Continuous Glucose Monitoring",
        "Microbiome-Based Therapeutics Shape the Gut Microbiome and Improve Metabolic Syndrome",
        "Massively Parallel Screening of Protein Design Space Using Machine Learning",
        "PROTAC Degraders for Previously Undruggable Transcription Factors in Cancer"
      ],
      "similarity_score": 0.6375582218170166,
      "subdomains": [
        "Biotech",
        "Vaccines"
      ],
      "summary_text": "No summary available",
      "technologies": [
        "lipid nanoparticles",
        "mRNA vaccines",
        "infectious disease"
      ],
      "title": "RNA-Based Vaccine Platform for Infectious Diseases"
    },
    {
      "assignees": [],
      "authors": [
        "Li, Haoyang",
        "Schulz, Daniel",
        "Thrane, Kristine",
        "Larsson, Ludvig",
        "Pe'er, Dana"
      ],
      "country": "United States",
      "cpcs": [],
      "data_quality_score": 0.92,
      "domain": "Healthcare",
      "id": "journals_BT-JRN-003",
      "inventors": [],
      "ipcs": [],
      "keywords": [
        "spatial transcriptomics",
        "tumor microenvironment",
        "cancer",
        "gene expression",
        "precision medicine"
      ],
      "knowledge_type": "journal",
      "publication_date": "2022-09-15",
      "publishers": [
        "Cell"
      ],
      "related_titles": [
        "Method for mRNA Delivery Using Lipid Nanoparticles",
        "CRISPR-Cas9 System for Targeted Gene Editing",
        "Bispecific Antibodies Targeting PD-1 and CTLA-4",
        "Engineered CAR-T Cells with Enhanced Tumor Targeting",
        "Microbiome-Based Therapeutics for Inflammatory Bowel Disease",
        "Scalable Process for Manufacturing Exosome Therapeutics",
        "Synthetic Biology Platform for On-Demand Therapeutic Protein Production",
        "AI-Based Platform for De Novo Protein Design",
        "Biodegradable Scaffolds for 3D Bioprinting of Functional Tissues",
        "High-Throughput Screening Platform for Antibody Discovery",
        "Engineered Bacterial Strains for Targeted Colorectal Cancer Therapy",
        "RNA-Based Vaccine Platform for Infectious Diseases",
        "Organs-on-Chips for Drug Toxicity Testing",
        "Machine Learning Platform for Predicting Drug-Target Interactions",
        "Nanobody Therapeutics for Neurodegenerative Diseases",
        "Gene Therapy for Age-Related Macular Degeneration",
        "Continuous Manufacturing Process for mRNA Vaccines",
        "PROTAC Technology for Protein Degradation",
        "Real-Time Pathogen Detection System Using Metagenomic Sequencing",
        "Single-Cell Multi-omics Analysis of the Immune Response in COVID-19",
        "CRISPR-Engineered T Cells in Patients with Refractory Cancer",
        "In Vivo Base Editing Corrects Hutchinson–Gilford Progeria Syndrome in Mice",
        "Engineered Living Materials: Prospects and Challenges for Using Biological Systems to Direct the Assembly of Smart Materials",
        "Intestinal Organoids as a Tool for Inflammatory Bowel Disease Research",
        "Enzyme-Free Biosensor for Continuous Glucose Monitoring",
        "Microbiome-Based Therapeutics Shape the Gut Microbiome and Improve Metabolic Syndrome",
        "Massively Parallel Screening of Protein Design Space Using Machine Learning",
        "PROTAC Degraders for Previously Undruggable Transcription Factors in Cancer"
      ],
      "similarity_score": 0.6325740814208984,
      "subdomains": [
        "Biotech",
        "Oncology"
      ],
      "summary_text": "No summary available",
      "technologies": [],
      "title": "Spatial Transcriptomics Reveals Insights into the Tumor Microenvironment"
    },
    {
      "assignees": [
        "NanoTherapeutics, Inc."
      ],
      "authors": [],
      "country": "United States",
      "cpcs": [
        "A61K9/127",
        "A61K47/24",
        "C12N15/88"
      ],
      "data_quality_score": 0.95,
      "domain": "Healthcare",
      "id": "patents_BT-PAT-001",
      "inventors": [
        "Chen, Li-Qiang",
        "Rodriguez, Maria",
        "Patel, Amit K."
      ],
      "ipcs": [
        "A61K9/127",
        "A61K47/24",
        "C12N15/88"
      ],
      "keywords": [
        "mRNA delivery",
        "LNP",
        "nanoparticle",
        "gene therapy"
      ],
      "knowledge_type": "patent",
      "publication_date": "2020-05-12",
      "publishers": [],
      "related_titles": [
        "Gene Therapy for Age-Related Macular Degeneration",
        "In Vivo Base Editing Corrects Hutchinson–Gilford Progeria Syndrome in Mice",
        "RNA-Based Vaccine Platform for Infectious Diseases",
        "Continuous Manufacturing Process for mRNA Vaccines",
        "CRISPR-Cas9 System for Targeted Gene Editing",
        "Bispecific Antibodies Targeting PD-1 and CTLA-4",
        "Engineered CAR-T Cells with Enhanced Tumor Targeting",
        "Microbiome-Based Therapeutics for Inflammatory Bowel Disease",
        "Scalable Process for Manufacturing Exosome Therapeutics",
        "Synthetic Biology Platform for On-Demand Therapeutic Protein Production",
        "AI-Based Platform for De Novo Protein Design",
        "Biodegradable Scaffolds for 3D Bioprinting of Functional Tissues",
        "High-Throughput Screening Platform for Antibody Discovery",
        "Engineered Bacterial Strains for Targeted Colorectal Cancer Therapy",
        "Organs-on-Chips for Drug Toxicity Testing",
        "Machine Learning Platform for Predicting Drug-Target Interactions",
        "Nanobody Therapeutics for Neurodegenerative Diseases",
        "PROTAC Technology for Protein Degradation",
        "Real-Time Pathogen Detection System Using Metagenomic Sequencing",
        "Single-Cell Multi-omics Analysis of the Immune Response in COVID-19",
        "CRISPR-Engineered T Cells in Patients with Refractory Cancer",
        "Spatial Transcriptomics Reveals Insights into the Tumor Microenvironment",
        "Engineered Living Materials: Prospects and Challenges for Using Biological Systems to Direct the Assembly of Smart Materials",
        "Intestinal Organoids as a Tool for Inflammatory Bowel Disease Research",
        "Enzyme-Free Biosensor for Continuous Glucose Monitoring",
        "Microbiome-Based Therapeutics Shape the Gut Microbiome and Improve Metabolic Syndrome",
        "Massively Parallel Screening of Protein Design Space Using Machine Learning",
        "PROTAC Degraders for Previously Undruggable Transcription Factors in Cancer"
      ],
      "similarity_score": 0.6299538612365723,
      "subdomains": [
        "Biotech",
        "Drug Delivery"
      ],
      "summary_text": "No summary available",
      "technologies": [
        "mRNA",
        "lipid nanoparticles",
        "drug delivery"
      ],
      "title": "Method for mRNA Delivery Using Lipid Nanoparticles"
    },
    {
      "assignees": [
        "BacteriaTx Inc."
      ],
      "authors": [],
      "country": "United States",
      "cpcs": [
        "A61P35/00",
        "A61K35/74",
        "C12N1/21"
      ],
      "data_quality_score": 0.87,
      "domain": "Healthcare",
      "id": "patents_BT-PAT-011",
      "inventors": [
        "Danino, Tal",
        "Leventhal, Daniel S.",
        "Zhang, Shuyi"
      ],
      "ipcs": [
        "A61P35/00",
        "A61K35/74",
        "C12N1/21"
      ],
      "keywords": [
        "synthetic biology",
        "engineered bacteria",
        "cancer therapy",
        "probiotic"
      ],
      "knowledge_type": "patent",
      "publication_date": "2022-12-08",
      "publishers": [],
      "related_titles": [
        "Method for mRNA Delivery Using Lipid Nanoparticles",
        "CRISPR-Cas9 System for Targeted Gene Editing",
        "Bispecific Antibodies Targeting PD-1 and CTLA-4",
        "Engineered CAR-T Cells with Enhanced Tumor Targeting",
        "Microbiome-Based Therapeutics for Inflammatory Bowel Disease",
        "Scalable Process for Manufacturing Exosome Therapeutics",
        "Synthetic Biology Platform for On-Demand Therapeutic Protein Production",
        "AI-Based Platform for De Novo Protein Design",
        "Biodegradable Scaffolds for 3D Bioprinting of Functional Tissues",
        "High-Throughput Screening Platform for Antibody Discovery",
        "RNA-Based Vaccine Platform for Infectious Diseases",
        "Organs-on-Chips for Drug Toxicity Testing",
        "Machine Learning Platform for Predicting Drug-Target Interactions",
        "Nanobody Therapeutics for Neurodegenerative Diseases",
        "Gene Therapy for Age-Related Macular Degeneration",
        "Continuous Manufacturing Process for mRNA Vaccines",
        "PROTAC Technology for Protein Degradation",
        "Real-Time Pathogen Detection System Using Metagenomic Sequencing",
        "Single-Cell Multi-omics Analysis of the Immune Response in COVID-19",
        "CRISPR-Engineered T Cells in Patients with Refractory Cancer",
        "Spatial Transcriptomics Reveals Insights into the Tumor Microenvironment",
        "In Vivo Base Editing Corrects Hutchinson–Gilford Progeria Syndrome in Mice",
        "Engineered Living Materials: Prospects and Challenges for Using Biological Systems to Direct the Assembly of Smart Materials",
        "Intestinal Organoids as a Tool for Inflammatory Bowel Disease Research",
        "Enzyme-Free Biosensor for Continuous Glucose Monitoring",
        "Microbiome-Based Therapeutics Shape the Gut Microbiome and Improve Metabolic Syndrome",
        "Massively Parallel Screening of Protein Design Space Using Machine Learning",
        "PROTAC Degraders for Previously Undruggable Transcription Factors in Cancer"
      ],
      "similarity_score": 0.6246802806854248,
      "subdomains": [
        "Biotech",
        "Microbiome"
      ],
      "summary_text": "No summary available",
      "technologies": [
        "genetic engineering",
        "synthetic biology",
        "bacterial therapeutics"
      ],
      "title": "Engineered Bacterial Strains for Targeted Colorectal Cancer Therapy"
    },
    {
      "assignees": [
        "Continuous Biologics Inc."
      ],
      "authors": [],
      "country": "United States",
      "cpcs": [
        "A61K9/127",
        "C12P19/34",
        "C12N15/10"
      ],
      "data_quality_score": 0.87,
      "domain": "Healthcare",
      "id": "patents_BT-PAT-017",
      "inventors": [
        "Trout, Bernhardt L.",
        "Jensen, Klavs F.",
        "Chakravarthy, Ankur"
      ],
      "ipcs": [
        "A61K9/127",
        "C12N15/10",
        "C12P19/34"
      ],
      "keywords": [
        "biomanufacturing",
        "continuous manufacturing",
        "mRNA vaccine",
        "process intensification"
      ],
      "knowledge_type": "patent",
      "publication_date": "2022-08-11",
      "publishers": [],
      "related_titles": [
        "Method for mRNA Delivery Using Lipid Nanoparticles",
        "CRISPR-Cas9 System for Targeted Gene Editing",
        "Bispecific Antibodies Targeting PD-1 and CTLA-4",
        "Engineered CAR-T Cells with Enhanced Tumor Targeting",
        "Microbiome-Based Therapeutics for Inflammatory Bowel Disease",
        "Scalable Process for Manufacturing Exosome Therapeutics",
        "Synthetic Biology Platform for On-Demand Therapeutic Protein Production",
        "AI-Based Platform for De Novo Protein Design",
        "Biodegradable Scaffolds for 3D Bioprinting of Functional Tissues",
        "High-Throughput Screening Platform for Antibody Discovery",
        "Engineered Bacterial Strains for Targeted Colorectal Cancer Therapy",
        "RNA-Based Vaccine Platform for Infectious Diseases",
        "Organs-on-Chips for Drug Toxicity Testing",
        "Machine Learning Platform for Predicting Drug-Target Interactions",
        "Nanobody Therapeutics for Neurodegenerative Diseases",
        "Gene Therapy for Age-Related Macular Degeneration",
        "PROTAC Technology for Protein Degradation",
        "Real-Time Pathogen Detection System Using Metagenomic Sequencing",
        "Single-Cell Multi-omics Analysis of the Immune Response in COVID-19",
        "CRISPR-Engineered T Cells in Patients with Refractory Cancer",
        "Spatial Transcriptomics Reveals Insights into the Tumor Microenvironment",
        "In Vivo Base Editing Corrects Hutchinson–Gilford Progeria Syndrome in Mice",
        "Engineered Living Materials: Prospects and Challenges for Using Biological Systems to Direct the Assembly of Smart Materials",
        "Intestinal Organoids as a Tool for Inflammatory Bowel Disease Research",
        "Enzyme-Free Biosensor for Continuous Glucose Monitoring",
        "Microbiome-Based Therapeutics Shape the Gut Microbiome and Improve Metabolic Syndrome",
        "Massively Parallel Screening of Protein Design Space Using Machine Learning",
        "PROTAC Degraders for Previously Undruggable Transcription Factors in Cancer"
      ],
      "similarity_score": 0.6222655773162842,
      "subdomains": [
        "Biotech",
        "Biologics Manufacturing"
      ],
      "summary_text": "No summary available",
      "technologies": [
        "continuous manufacturing",
        "mRNA production",
        "process intensification"
      ],
      "title": "Continuous Manufacturing Process for mRNA Vaccines"
    },
    {
      "assignees": [],
      "authors": [
        "Burslem, George M.",
        "Schultz, David C.",
        "Bondeson, Daniel P.",
        "Eide, Christopher A.",
        "Crews, Craig M."
      ],
      "country": "United States",
      "cpcs": [],
      "data_quality_score": 0.93,
      "domain": "Healthcare",
      "id": "journals_BT-JRN-010",
      "inventors": [],
      "ipcs": [],
      "keywords": [
        "cancer therapy",
        "PROTAC",
        "undruggable targets",
        "transcription factors",
        "targeted protein degradation"
      ],
      "knowledge_type": "journal",
      "publication_date": "2023-04-18",
      "publishers": [
        "Science Translational Medicine"
      ],
      "related_titles": [
        "Method for mRNA Delivery Using Lipid Nanoparticles",
        "CRISPR-Cas9 System for Targeted Gene Editing",
        "Bispecific Antibodies Targeting PD-1 and CTLA-4",
        "Engineered CAR-T Cells with Enhanced Tumor Targeting",
        "Microbiome-Based Therapeutics for Inflammatory Bowel Disease",
        "Scalable Process for Manufacturing Exosome Therapeutics",
        "Synthetic Biology Platform for On-Demand Therapeutic Protein Production",
        "AI-Based Platform for De Novo Protein Design",
        "Biodegradable Scaffolds for 3D Bioprinting of Functional Tissues",
        "High-Throughput Screening Platform for Antibody Discovery",
        "Engineered Bacterial Strains for Targeted Colorectal Cancer Therapy",
        "RNA-Based Vaccine Platform for Infectious Diseases",
        "Organs-on-Chips for Drug Toxicity Testing",
        "Machine Learning Platform for Predicting Drug-Target Interactions",
        "Nanobody Therapeutics for Neurodegenerative Diseases",
        "Gene Therapy for Age-Related Macular Degeneration",
        "Continuous Manufacturing Process for mRNA Vaccines",
        "PROTAC Technology for Protein Degradation",
        "Real-Time Pathogen Detection System Using Metagenomic Sequencing",
        "Single-Cell Multi-omics Analysis of the Immune Response in COVID-19",
        "CRISPR-Engineered T Cells in Patients with Refractory Cancer",
        "Spatial Transcriptomics Reveals Insights into the Tumor Microenvironment",
        "In Vivo Base Editing Corrects Hutchinson–Gilford Progeria Syndrome in Mice",
        "Engineered Living Materials: Prospects and Challenges for Using Biological Systems to Direct the Assembly of Smart Materials",
        "Intestinal Organoids as a Tool for Inflammatory Bowel Disease Research",
        "Enzyme-Free Biosensor for Continuous Glucose Monitoring",
        "Microbiome-Based Therapeutics Shape the Gut Microbiome and Improve Metabolic Syndrome",
        "Massively Parallel Screening of Protein Design Space Using Machine Learning"
      ],
      "similarity_score": 0.6203403472900391,
      "subdomains": [
        "Biotech",
        "Drug Discovery"
      ],
      "summary_text": "No summary available",
      "technologies": [],
      "title": "PROTAC Degraders for Previously Undruggable Transcription Factors in Cancer"
    },
    {
      "assignees": [
        "NeuroNano Therapeutics"
      ],
      "authors": [],
      "country": "United States",
      "cpcs": [
        "C07K16/18",
        "A61K39/395",
        "A61P25/28"
      ],
      "data_quality_score": 0.86,
      "domain": "Healthcare",
      "id": "patents_BT-PAT-015",
      "inventors": [
        "Muyldermans, Serge",
        "Steyaert, Jan",
        "De Genst, Erwin"
      ],
      "ipcs": [
        "A61K39/395",
        "C07K16/18",
        "A61P25/28"
      ],
      "keywords": [
        "nanobody",
        "neurodegenerative disease",
        "blood-brain barrier",
        "protein misfolding"
      ],
      "knowledge_type": "patent",
      "publication_date": "2021-04-08",
      "publishers": [],
      "related_titles": [
        "Method for mRNA Delivery Using Lipid Nanoparticles",
        "CRISPR-Cas9 System for Targeted Gene Editing",
        "Bispecific Antibodies Targeting PD-1 and CTLA-4",
        "Engineered CAR-T Cells with Enhanced Tumor Targeting",
        "Microbiome-Based Therapeutics for Inflammatory Bowel Disease",
        "Scalable Process for Manufacturing Exosome Therapeutics",
        "Synthetic Biology Platform for On-Demand Therapeutic Protein Production",
        "AI-Based Platform for De Novo Protein Design",
        "Biodegradable Scaffolds for 3D Bioprinting of Functional Tissues",
        "High-Throughput Screening Platform for Antibody Discovery",
        "Engineered Bacterial Strains for Targeted Colorectal Cancer Therapy",
        "RNA-Based Vaccine Platform for Infectious Diseases",
        "Organs-on-Chips for Drug Toxicity Testing",
        "Machine Learning Platform for Predicting Drug-Target Interactions",
        "Gene Therapy for Age-Related Macular Degeneration",
        "Continuous Manufacturing Process for mRNA Vaccines",
        "PROTAC Technology for Protein Degradation",
        "Real-Time Pathogen Detection System Using Metagenomic Sequencing",
        "Single-Cell Multi-omics Analysis of the Immune Response in COVID-19",
        "CRISPR-Engineered T Cells in Patients with Refractory Cancer",
        "Spatial Transcriptomics Reveals Insights into the Tumor Microenvironment",
        "In Vivo Base Editing Corrects Hutchinson–Gilford Progeria Syndrome in Mice",
        "Engineered Living Materials: Prospects and Challenges for Using Biological Systems to Direct the Assembly of Smart Materials",
        "Intestinal Organoids as a Tool for Inflammatory Bowel Disease Research",
        "Enzyme-Free Biosensor for Continuous Glucose Monitoring",
        "Microbiome-Based Therapeutics Shape the Gut Microbiome and Improve Metabolic Syndrome",
        "Massively Parallel Screening of Protein Design Space Using Machine Learning",
        "PROTAC Degraders for Previously Undruggable Transcription Factors in Cancer"
      ],
      "similarity_score": 0.6186943054199219,
      "subdomains": [
        "Biotech",
        "Neuroscience"
      ],
      "summary_text": "No summary available",
      "technologies": [
        "nanobodies",
        "blood-brain barrier",
        "protein targeting"
      ],
      "title": "Nanobody Therapeutics for Neurodegenerative Diseases"
    },
    {
      "assignees": [
        "UrbanAir Systems"
      ],
      "authors": [],
      "country": "United States",
      "cpcs": [
        "G08G5/0013",
        "H04L67/12",
        "G08G5/045"
      ],
      "data_quality_score": 0.87,
      "domain": "Mobility",
      "id": "patents_MB-PAT-004",
      "inventors": [
        "Yang, Xiaoqian",
        "Kopardekar, Parimal",
        "Johnson, Marcus"
      ],
      "ipcs": [
        "G08G5/00",
        "H04L67/12",
        "G08G5/04"
      ],
      "keywords": [
        "urban air mobility",
        "eVTOL",
        "air traffic management",
        "UAM"
      ],
      "knowledge_type": "patent",
      "publication_date": "2023-01-26",
      "publishers": [],
      "related_titles": [
        "Urban Air Mobility: Infrastructure Requirements and Operational Challenges",
        "Sustainable Aviation Fuel Production from Municipal Waste",
        "AI-Enabled Traffic Signal Control System",
        "Machine Learning Approaches for Traffic Signal Control: A Comparative Analysis"
      ],
      "similarity_score": 0.6165573596954346,
      "subdomains": [
        "Urban Air Mobility",
        "Traffic Management"
      ],
      "summary_text": "No summary available",
      "technologies": [
        "urban air mobility",
        "air traffic management",
        "distributed systems"
      ],
      "title": "Urban Air Mobility Traffic Management System"
    },
    {
      "assignees": [
        "MedFly Systems"
      ],
      "authors": [],
      "country": "United States",
      "cpcs": [
        "B64C39/024",
        "G05D1/0088",
        "A61G3/00"
      ],
      "data_quality_score": 0.85,
      "domain": "Mobility",
      "id": "patents_MB-PAT-014",
      "inventors": [
        "Nguyen, Thuy",
        "Okonkwo, Chima",
        "Ramos, Isabella"
      ],
      "ipcs": [
        "B64C39/02",
        "G05D1/00",
        "A61G3/00"
      ],
      "keywords": [
        "medical delivery",
        "emergency response",
        "drone delivery",
        "healthcare logistics"
      ],
      "knowledge_type": "patent",
      "publication_date": "2022-06-16",
      "publishers": [],
      "related_titles": [],
      "similarity_score": 0.6164381504058838,
      "subdomains": [
        "Drone Technology",
        "Healthcare Logistics"
      ],
      "summary_text": "No summary available",
      "technologies": [
        "autonomous drones",
        "medical logistics",
        "remote sensing"
      ],
      "title": "Drone-Based Emergency Medical Supply Delivery System"
    }
  ],
  "insights": [
    "The emergence of RNA-based vaccine platforms demonstrates a significant investment in mRNA technology, highlighting its relevance for infectious disease management and response to public health crises.",
    "Innovations in lipid nanoparticles for mRNA delivery reflect advancements in drug delivery systems, facilitating more effective therapeutic applications in gene therapy and vaccine deployment.",
    "Continuous manufacturing processes for mRNA vaccines are becoming essential, streamlining production and enhancing the scalability of vaccine development, which was critical during the COVID-19 pandemic."
  ],
  "isData": true,
  "message": "Successfully generated insights.",
  "notes": "The healthcare sector shows a robust trend towards mRNA technologies, supported by patents related to real-time pathogen detection systems and RNA-based vaccine platforms. With the recent advancements captured in patents about mRNA delivery and manufacturing, it's clear that innovation in this space is accelerating. Continuous manufacturing technologies are essential to meet the growing demand for mRNA vaccines, indicating a strategic opportunity for firms to enhance production capabilities. Additionally, as discoveries regarding lipid nanoparticles and their applications in vaccine efficacy arise, there's a critical need to invest in these areas to further advance therapeutic solutions for infectious diseases. By aligning R&D focus on scalable processes and fostering collaborations in lipid nanoparticle technology, organizations position themselves favorably in the evolving landscape of mRNA-based therapeutics.",
  "prompt": "MRNA",
  "recommendations": [
    "Invest in research and development of scalable biomanufacturing processes to keep pace with the increasing demand for mRNA vaccines and therapies.",
    "Explore partnerships with biotechnology firms specializing in lipid nanoparticle technology to enhance drug delivery systems for mRNA therapies, potentially improving patient outcomes."
  ],
  "relevant_trends": [
    {
      "assignees": [
        "RapidDx Genomics"
      ],
      "authors": [],
      "country": "United States",
      "cpcs": [
        "C12Q1/6806",
        "G16B30/00",
        "G16H50/70"
      ],
      "data_quality_score": 0.88,
      "domain": "Healthcare",
      "id": "patents_BT-PAT-020",
      "inventors": [
        "Schatz, Michael C.",
        "Phillippy, Adam M.",
        "Zimin, Aleksey V."
      ],
      "ipcs": [
        "C12Q1/6806",
        "G16B30/00",
        "G16H50/70"
      ],
      "keywords": [
        "metagenomic",
        "pathogen detection",
        "antimicrobial resistance",
        "nanopore sequencing"
      ],
      "knowledge_type": "patent",
      "publication_date": "2023-05-04",
      "publishers": [],
      "related_titles": [
        "Method for mRNA Delivery Using Lipid Nanoparticles",
        "CRISPR-Cas9 System for Targeted Gene Editing",
        "Bispecific Antibodies Targeting PD-1 and CTLA-4",
        "Engineered CAR-T Cells with Enhanced Tumor Targeting",
        "Microbiome-Based Therapeutics for Inflammatory Bowel Disease",
        "Scalable Process for Manufacturing Exosome Therapeutics",
        "Synthetic Biology Platform for On-Demand Therapeutic Protein Production",
        "AI-Based Platform for De Novo Protein Design",
        "Biodegradable Scaffolds for 3D Bioprinting of Functional Tissues",
        "High-Throughput Screening Platform for Antibody Discovery",
        "Engineered Bacterial Strains for Targeted Colorectal Cancer Therapy",
        "RNA-Based Vaccine Platform for Infectious Diseases",
        "Organs-on-Chips for Drug Toxicity Testing",
        "Machine Learning Platform for Predicting Drug-Target Interactions",
        "Nanobody Therapeutics for Neurodegenerative Diseases",
        "Gene Therapy for Age-Related Macular Degeneration",
        "Continuous Manufacturing Process for mRNA Vaccines",
        "PROTAC Technology for Protein Degradation",
        "Single-Cell Multi-omics Analysis of the Immune Response in COVID-19",
        "CRISPR-Engineered T Cells in Patients with Refractory Cancer",
        "Spatial Transcriptomics Reveals Insights into the Tumor Microenvironment",
        "In Vivo Base Editing Corrects Hutchinson–Gilford Progeria Syndrome in Mice",
        "Engineered Living Materials: Prospects and Challenges for Using Biological Systems to Direct the Assembly of Smart Materials",
        "Intestinal Organoids as a Tool for Inflammatory Bowel Disease Research",
        "Enzyme-Free Biosensor for Continuous Glucose Monitoring",
        "Microbiome-Based Therapeutics Shape the Gut Microbiome and Improve Metabolic Syndrome",
        "Massively Parallel Screening of Protein Design Space Using Machine Learning",
        "PROTAC Degraders for Previously Undruggable Transcription Factors in Cancer"
      ],
      "similarity_score": 0.6647,
      "subdomains": [
        "Biotech",
        "Diagnostics"
      ],
      "summary_text": "No summary available",
      "technologies": [
        "metagenomic sequencing",
        "nanopore technology",
        "bioinformatics"
      ],
      "title": "Real-Time Pathogen Detection System Using Metagenomic Sequencing"
    },
    {
      "assignees": [
        "RapidVax Inc."
      ],
      "authors": [],
      "country": "United States",
      "cpcs": [
        "C12N15/88",
        "A61K39/00",
        "A61K47/69"
      ],
      "data_quality_score": 0.93,
      "domain": "Healthcare",
      "id": "patents_BT-PAT-012",
      "inventors": [
        "Karikó, Katalin",
        "Weissman, Drew",
        "Pardi, Norbert"
      ],
      "ipcs": [
        "C12N15/88",
        "A61K39/00",
        "A61K47/69"
      ],
      "keywords": [
        "mRNA",
        "vaccine",
        "infectious disease",
        "lipid nanoparticle"
      ],
      "knowledge_type": "patent",
      "publication_date": "2019-09-05",
      "publishers": [],
      "related_titles": [
        "Method for mRNA Delivery Using Lipid Nanoparticles",
        "CRISPR-Cas9 System for Targeted Gene Editing",
        "Bispecific Antibodies Targeting PD-1 and CTLA-4",
        "Engineered CAR-T Cells with Enhanced Tumor Targeting",
        "Microbiome-Based Therapeutics for Inflammatory Bowel Disease",
        "Scalable Process for Manufacturing Exosome Therapeutics",
        "Synthetic Biology Platform for On-Demand Therapeutic Protein Production",
        "AI-Based Platform for De Novo Protein Design",
        "Biodegradable Scaffolds for 3D Bioprinting of Functional Tissues",
        "High-Throughput Screening Platform for Antibody Discovery",
        "Engineered Bacterial Strains for Targeted Colorectal Cancer Therapy",
        "Organs-on-Chips for Drug Toxicity Testing",
        "Machine Learning Platform for Predicting Drug-Target Interactions",
        "Nanobody Therapeutics for Neurodegenerative Diseases",
        "Gene Therapy for Age-Related Macular Degeneration",
        "Continuous Manufacturing Process for mRNA Vaccines",
        "PROTAC Technology for Protein Degradation",
        "Real-Time Pathogen Detection System Using Metagenomic Sequencing",
        "Single-Cell Multi-omics Analysis of the Immune Response in COVID-19",
        "CRISPR-Engineered T Cells in Patients with Refractory Cancer",
        "Spatial Transcriptomics Reveals Insights into the Tumor Microenvironment",
        "In Vivo Base Editing Corrects Hutchinson–Gilford Progeria Syndrome in Mice",
        "Engineered Living Materials: Prospects and Challenges for Using Biological Systems to Direct the Assembly of Smart Materials",
        "Intestinal Organoids as a Tool for Inflammatory Bowel Disease Research",
        "Enzyme-Free Biosensor for Continuous Glucose Monitoring",
        "Microbiome-Based Therapeutics Shape the Gut Microbiome and Improve Metabolic Syndrome",
        "Massively Parallel Screening of Protein Design Space Using Machine Learning",
        "PROTAC Degraders for Previously Undruggable Transcription Factors in Cancer"
      ],
      "similarity_score": 0.6376,
      "subdomains": [
        "Biotech",
        "Vaccines"
      ],
      "summary_text": "No summary available",
      "technologies": [
        "lipid nanoparticles",
        "mRNA vaccines",
        "infectious disease"
      ],
      "title": "RNA-Based Vaccine Platform for Infectious Diseases"
    },
    {
      "assignees": [],
      "authors": [
        "Li, Haoyang",
        "Schulz, Daniel",
        "Thrane, Kristine",
        "Larsson, Ludvig",
        "Pe'er, Dana"
      ],
      "country": "United States",
      "cpcs": [],
      "data_quality_score": 0.92,
      "domain": "Healthcare",
      "id": "journals_BT-JRN-003",
      "inventors": [],
      "ipcs": [],
      "keywords": [
        "spatial transcriptomics",
        "tumor microenvironment",
        "cancer",
        "gene expression",
        "precision medicine"
      ],
      "knowledge_type": "journal",
      "publication_date": "2022-09-15",
      "publishers": [
        "Cell"
      ],
      "related_titles": [
        "Method for mRNA Delivery Using Lipid Nanoparticles",
        "CRISPR-Cas9 System for Targeted Gene Editing",
        "Bispecific Antibodies Targeting PD-1 and CTLA-4",
        "Engineered CAR-T Cells with Enhanced Tumor Targeting",
        "Microbiome-Based Therapeutics for Inflammatory Bowel Disease",
        "Scalable Process for Manufacturing Exosome Therapeutics",
        "Synthetic Biology Platform for On-Demand Therapeutic Protein Production",
        "AI-Based Platform for De Novo Protein Design",
        "Biodegradable Scaffolds for 3D Bioprinting of Functional Tissues",
        "High-Throughput Screening Platform for Antibody Discovery",
        "Engineered Bacterial Strains for Targeted Colorectal Cancer Therapy",
        "RNA-Based Vaccine Platform for Infectious Diseases",
        "Organs-on-Chips for Drug Toxicity Testing",
        "Machine Learning Platform for Predicting Drug-Target Interactions",
        "Nanobody Therapeutics for Neurodegenerative Diseases",
        "Gene Therapy for Age-Related Macular Degeneration",
        "Continuous Manufacturing Process for mRNA Vaccines",
        "PROTAC Technology for Protein Degradation",
        "Real-Time Pathogen Detection System Using Metagenomic Sequencing",
        "Single-Cell Multi-omics Analysis of the Immune Response in COVID-19",
        "CRISPR-Engineered T Cells in Patients with Refractory Cancer",
        "In Vivo Base Editing Corrects Hutchinson–Gilford Progeria Syndrome in Mice",
        "Engineered Living Materials: Prospects and Challenges for Using Biological Systems to Direct the Assembly of Smart Materials",
        "Intestinal Organoids as a Tool for Inflammatory Bowel Disease Research",
        "Enzyme-Free Biosensor for Continuous Glucose Monitoring",
        "Microbiome-Based Therapeutics Shape the Gut Microbiome and Improve Metabolic Syndrome",
        "Massively Parallel Screening of Protein Design Space Using Machine Learning",
        "PROTAC Degraders for Previously Undruggable Transcription Factors in Cancer"
      ],
      "similarity_score": 0.6326,
      "subdomains": [
        "Biotech",
        "Oncology"
      ],
      "summary_text": "No summary available",
      "technologies": [],
      "title": "Spatial Transcriptomics Reveals Insights into the Tumor Microenvironment"
    },
    {
      "assignees": [
        "NanoTherapeutics, Inc."
      ],
      "authors": [],
      "country": "United States",
      "cpcs": [
        "A61K9/127",
        "A61K47/24",
        "C12N15/88"
      ],
      "data_quality_score": 0.95,
      "domain": "Healthcare",
      "id": "patents_BT-PAT-001",
      "inventors": [
        "Chen, Li-Qiang",
        "Rodriguez, Maria",
        "Patel, Amit K."
      ],
      "ipcs": [
        "A61K9/127",
        "A61K47/24",
        "C12N15/88"
      ],
      "keywords": [
        "mRNA delivery",
        "LNP",
        "nanoparticle",
        "gene therapy"
      ],
      "knowledge_type": "patent",
      "publication_date": "2020-05-12",
      "publishers": [],
      "related_titles": [
        "Gene Therapy for Age-Related Macular Degeneration",
        "In Vivo Base Editing Corrects Hutchinson–Gilford Progeria Syndrome in Mice",
        "RNA-Based Vaccine Platform for Infectious Diseases",
        "Continuous Manufacturing Process for mRNA Vaccines",
        "CRISPR-Cas9 System for Targeted Gene Editing",
        "Bispecific Antibodies Targeting PD-1 and CTLA-4",
        "Engineered CAR-T Cells with Enhanced Tumor Targeting",
        "Microbiome-Based Therapeutics for Inflammatory Bowel Disease",
        "Scalable Process for Manufacturing Exosome Therapeutics",
        "Synthetic Biology Platform for On-Demand Therapeutic Protein Production",
        "AI-Based Platform for De Novo Protein Design",
        "Biodegradable Scaffolds for 3D Bioprinting of Functional Tissues",
        "High-Throughput Screening Platform for Antibody Discovery",
        "Engineered Bacterial Strains for Targeted Colorectal Cancer Therapy",
        "Organs-on-Chips for Drug Toxicity Testing",
        "Machine Learning Platform for Predicting Drug-Target Interactions",
        "Nanobody Therapeutics for Neurodegenerative Diseases",
        "PROTAC Technology for Protein Degradation",
        "Real-Time Pathogen Detection System Using Metagenomic Sequencing",
        "Single-Cell Multi-omics Analysis of the Immune Response in COVID-19",
        "CRISPR-Engineered T Cells in Patients with Refractory Cancer",
        "Spatial Transcriptomics Reveals Insights into the Tumor Microenvironment",
        "Engineered Living Materials: Prospects and Challenges for Using Biological Systems to Direct the Assembly of Smart Materials",
        "Intestinal Organoids as a Tool for Inflammatory Bowel Disease Research",
        "Enzyme-Free Biosensor for Continuous Glucose Monitoring",
        "Microbiome-Based Therapeutics Shape the Gut Microbiome and Improve Metabolic Syndrome",
        "Massively Parallel Screening of Protein Design Space Using Machine Learning",
        "PROTAC Degraders for Previously Undruggable Transcription Factors in Cancer"
      ],
      "similarity_score": 0.63,
      "subdomains": [
        "Biotech",
        "Drug Delivery"
      ],
      "summary_text": "No summary available",
      "technologies": [
        "mRNA",
        "lipid nanoparticles",
        "drug delivery"
      ],
      "title": "Method for mRNA Delivery Using Lipid Nanoparticles"
    },
    {
      "assignees": [
        "BacteriaTx Inc."
      ],
      "authors": [],
      "country": "United States",
      "cpcs": [
        "A61P35/00",
        "A61K35/74",
        "C12N1/21"
      ],
      "data_quality_score": 0.87,
      "domain": "Healthcare",
      "id": "patents_BT-PAT-011",
      "inventors": [
        "Danino, Tal",
        "Leventhal, Daniel S.",
        "Zhang, Shuyi"
      ],
      "ipcs": [
        "A61P35/00",
        "A61K35/74",
        "C12N1/21"
      ],
      "keywords": [
        "synthetic biology",
        "engineered bacteria",
        "cancer therapy",
        "probiotic"
      ],
      "knowledge_type": "patent",
      "publication_date": "2022-12-08",
      "publishers": [],
      "related_titles": [
        "Method for mRNA Delivery Using Lipid Nanoparticles",
        "CRISPR-Cas9 System for Targeted Gene Editing",
        "Bispecific Antibodies Targeting PD-1 and CTLA-4",
        "Engineered CAR-T Cells with Enhanced Tumor Targeting",
        "Microbiome-Based Therapeutics for Inflammatory Bowel Disease",
        "Scalable Process for Manufacturing Exosome Therapeutics",
        "Synthetic Biology Platform for On-Demand Therapeutic Protein Production",
        "AI-Based Platform for De Novo Protein Design",
        "Biodegradable Scaffolds for 3D Bioprinting of Functional Tissues",
        "High-Throughput Screening Platform for Antibody Discovery",
        "RNA-Based Vaccine Platform for Infectious Diseases",
        "Organs-on-Chips for Drug Toxicity Testing",
        "Machine Learning Platform for Predicting Drug-Target Interactions",
        "Nanobody Therapeutics for Neurodegenerative Diseases",
        "Gene Therapy for Age-Related Macular Degeneration",
        "Continuous Manufacturing Process for mRNA Vaccines",
        "PROTAC Technology for Protein Degradation",
        "Real-Time Pathogen Detection System Using Metagenomic Sequencing",
        "Single-Cell Multi-omics Analysis of the Immune Response in COVID-19",
        "CRISPR-Engineered T Cells in Patients with Refractory Cancer",
        "Spatial Transcriptomics Reveals Insights into the Tumor Microenvironment",
        "In Vivo Base Editing Corrects Hutchinson–Gilford Progeria Syndrome in Mice",
        "Engineered Living Materials: Prospects and Challenges for Using Biological Systems to Direct the Assembly of Smart Materials",
        "Intestinal Organoids as a Tool for Inflammatory Bowel Disease Research",
        "Enzyme-Free Biosensor for Continuous Glucose Monitoring",
        "Microbiome-Based Therapeutics Shape the Gut Microbiome and Improve Metabolic Syndrome",
        "Massively Parallel Screening of Protein Design Space Using Machine Learning",
        "PROTAC Degraders for Previously Undruggable Transcription Factors in Cancer"
      ],
      "similarity_score": 0.6247,
      "subdomains": [
        "Biotech",
        "Microbiome"
      ],
      "summary_text": "No summary available",
      "technologies": [
        "genetic engineering",
        "synthetic biology",
        "bacterial therapeutics"
      ],
      "title": "Engineered Bacterial Strains for Targeted Colorectal Cancer Therapy"
    },
    {
      "assignees": [
        "Continuous Biologics Inc."
      ],
      "authors": [],
      "country": "United States",
      "cpcs": [
        "A61K9/127",
        "C12P19/34",
        "C12N15/10"
      ],
      "data_quality_score": 0.87,
      "domain": "Healthcare",
      "id": "patents_BT-PAT-017",
      "inventors": [
        "Trout, Bernhardt L.",
        "Jensen, Klavs F.",
        "Chakravarthy, Ankur"
      ],
      "ipcs": [
        "A61K9/127",
        "C12N15/10",
        "C12P19/34"
      ],
      "keywords": [
        "biomanufacturing",
        "continuous manufacturing",
        "mRNA vaccine",
        "process intensification"
      ],
      "knowledge_type": "patent",
      "publication_date": "2022-08-11",
      "publishers": [],
      "related_titles": [
        "Method for mRNA Delivery Using Lipid Nanoparticles",
        "CRISPR-Cas9 System for Targeted Gene Editing",
        "Bispecific Antibodies Targeting PD-1 and CTLA-4",
        "Engineered CAR-T Cells with Enhanced Tumor Targeting",
        "Microbiome-Based Therapeutics for Inflammatory Bowel Disease",
        "Scalable Process for Manufacturing Exosome Therapeutics",
        "Synthetic Biology Platform for On-Demand Therapeutic Protein Production",
        "AI-Based Platform for De Novo Protein Design",
        "Biodegradable Scaffolds for 3D Bioprinting of Functional Tissues",
        "High-Throughput Screening Platform for Antibody Discovery",
        "Engineered Bacterial Strains for Targeted Colorectal Cancer Therapy",
        "RNA-Based Vaccine Platform for Infectious Diseases",
        "Organs-on-Chips for Drug Toxicity Testing",
        "Machine Learning Platform for Predicting Drug-Target Interactions",
        "Nanobody Therapeutics for Neurodegenerative Diseases",
        "Gene Therapy for Age-Related Macular Degeneration",
        "PROTAC Technology for Protein Degradation",
        "Real-Time Pathogen Detection System Using Metagenomic Sequencing",
        "Single-Cell Multi-omics Analysis of the Immune Response in COVID-19",
        "CRISPR-Engineered T Cells in Patients with Refractory Cancer",
        "Spatial Transcriptomics Reveals Insights into the Tumor Microenvironment",
        "In Vivo Base Editing Corrects Hutchinson–Gilford Progeria Syndrome in Mice",
        "Engineered Living Materials: Prospects and Challenges for Using Biological Systems to Direct the Assembly of Smart Materials",
        "Intestinal Organoids as a Tool for Inflammatory Bowel Disease Research",
        "Enzyme-Free Biosensor for Continuous Glucose Monitoring",
        "Microbiome-Based Therapeutics Shape the Gut Microbiome and Improve Metabolic Syndrome",
        "Massively Parallel Screening of Protein Design Space Using Machine Learning",
        "PROTAC Degraders for Previously Undruggable Transcription Factors in Cancer"
      ],
      "similarity_score": 0.6223,
      "subdomains": [
        "Biotech",
        "Biologics Manufacturing"
      ],
      "summary_text": "No summary available",
      "technologies": [
        "continuous manufacturing",
        "mRNA production",
        "process intensification"
      ],
      "title": "Continuous Manufacturing Process for mRNA Vaccines"
    },
    {
      "assignees": [],
      "authors": [
        "Burslem, George M.",
        "Schultz, David C.",
        "Bondeson, Daniel P.",
        "Eide, Christopher A.",
        "Crews, Craig M."
      ],
      "country": "United States",
      "cpcs": [],
      "data_quality_score": 0.93,
      "domain": "Healthcare",
      "id": "journals_BT-JRN-010",
      "inventors": [],
      "ipcs": [],
      "keywords": [
        "cancer therapy",
        "PROTAC",
        "undruggable targets",
        "transcription factors",
        "targeted protein degradation"
      ],
      "knowledge_type": "journal",
      "publication_date": "2023-04-18",
      "publishers": [
        "Science Translational Medicine"
      ],
      "related_titles": [
        "Method for mRNA Delivery Using Lipid Nanoparticles",
        "CRISPR-Cas9 System for Targeted Gene Editing",
        "Bispecific Antibodies Targeting PD-1 and CTLA-4",
        "Engineered CAR-T Cells with Enhanced Tumor Targeting",
        "Microbiome-Based Therapeutics for Inflammatory Bowel Disease",
        "Scalable Process for Manufacturing Exosome Therapeutics",
        "Synthetic Biology Platform for On-Demand Therapeutic Protein Production",
        "AI-Based Platform for De Novo Protein Design",
        "Biodegradable Scaffolds for 3D Bioprinting of Functional Tissues",
        "High-Throughput Screening Platform for Antibody Discovery",
        "Engineered Bacterial Strains for Targeted Colorectal Cancer Therapy",
        "RNA-Based Vaccine Platform for Infectious Diseases",
        "Organs-on-Chips for Drug Toxicity Testing",
        "Machine Learning Platform for Predicting Drug-Target Interactions",
        "Nanobody Therapeutics for Neurodegenerative Diseases",
        "Gene Therapy for Age-Related Macular Degeneration",
        "Continuous Manufacturing Process for mRNA Vaccines",
        "PROTAC Technology for Protein Degradation",
        "Real-Time Pathogen Detection System Using Metagenomic Sequencing",
        "Single-Cell Multi-omics Analysis of the Immune Response in COVID-19",
        "CRISPR-Engineered T Cells in Patients with Refractory Cancer",
        "Spatial Transcriptomics Reveals Insights into the Tumor Microenvironment",
        "In Vivo Base Editing Corrects Hutchinson–Gilford Progeria Syndrome in Mice",
        "Engineered Living Materials: Prospects and Challenges for Using Biological Systems to Direct the Assembly of Smart Materials",
        "Intestinal Organoids as a Tool for Inflammatory Bowel Disease Research",
        "Enzyme-Free Biosensor for Continuous Glucose Monitoring",
        "Microbiome-Based Therapeutics Shape the Gut Microbiome and Improve Metabolic Syndrome",
        "Massively Parallel Screening of Protein Design Space Using Machine Learning"
      ],
      "similarity_score": 0.6203,
      "subdomains": [
        "Biotech",
        "Drug Discovery"
      ],
      "summary_text": "No summary available",
      "technologies": [],
      "title": "PROTAC Degraders for Previously Undruggable Transcription Factors in Cancer"
    },
    {
      "assignees": [
        "NeuroNano Therapeutics"
      ],
      "authors": [],
      "country": "United States",
      "cpcs": [
        "C07K16/18",
        "A61K39/395",
        "A61P25/28"
      ],
      "data_quality_score": 0.86,
      "domain": "Healthcare",
      "id": "patents_BT-PAT-015",
      "inventors": [
        "Muyldermans, Serge",
        "Steyaert, Jan",
        "De Genst, Erwin"
      ],
      "ipcs": [
        "A61K39/395",
        "C07K16/18",
        "A61P25/28"
      ],
      "keywords": [
        "nanobody",
        "neurodegenerative disease",
        "blood-brain barrier",
        "protein misfolding"
      ],
      "knowledge_type": "patent",
      "publication_date": "2021-04-08",
      "publishers": [],
      "related_titles": [
        "Method for mRNA Delivery Using Lipid Nanoparticles",
        "CRISPR-Cas9 System for Targeted Gene Editing",
        "Bispecific Antibodies Targeting PD-1 and CTLA-4",
        "Engineered CAR-T Cells with Enhanced Tumor Targeting",
        "Microbiome-Based Therapeutics for Inflammatory Bowel Disease",
        "Scalable Process for Manufacturing Exosome Therapeutics",
        "Synthetic Biology Platform for On-Demand Therapeutic Protein Production",
        "AI-Based Platform for De Novo Protein Design",
        "Biodegradable Scaffolds for 3D Bioprinting of Functional Tissues",
        "High-Throughput Screening Platform for Antibody Discovery",
        "Engineered Bacterial Strains for Targeted Colorectal Cancer Therapy",
        "RNA-Based Vaccine Platform for Infectious Diseases",
        "Organs-on-Chips for Drug Toxicity Testing",
        "Machine Learning Platform for Predicting Drug-Target Interactions",
        "Gene Therapy for Age-Related Macular Degeneration",
        "Continuous Manufacturing Process for mRNA Vaccines",
        "PROTAC Technology for Protein Degradation",
        "Real-Time Pathogen Detection System Using Metagenomic Sequencing",
        "Single-Cell Multi-omics Analysis of the Immune Response in COVID-19",
        "CRISPR-Engineered T Cells in Patients with Refractory Cancer",
        "Spatial Transcriptomics Reveals Insights into the Tumor Microenvironment",
        "In Vivo Base Editing Corrects Hutchinson–Gilford Progeria Syndrome in Mice",
        "Engineered Living Materials: Prospects and Challenges for Using Biological Systems to Direct the Assembly of Smart Materials",
        "Intestinal Organoids as a Tool for Inflammatory Bowel Disease Research",
        "Enzyme-Free Biosensor for Continuous Glucose Monitoring",
        "Microbiome-Based Therapeutics Shape the Gut Microbiome and Improve Metabolic Syndrome",
        "Massively Parallel Screening of Protein Design Space Using Machine Learning",
        "PROTAC Degraders for Previously Undruggable Transcription Factors in Cancer"
      ],
      "similarity_score": 0.6187,
      "subdomains": [
        "Biotech",
        "Neuroscience"
      ],
      "summary_text": "No summary available",
      "technologies": [
        "nanobodies",
        "blood-brain barrier",
        "protein targeting"
      ],
      "title": "Nanobody Therapeutics for Neurodegenerative Diseases"
    },
    {
      "assignees": [
        "UrbanAir Systems"
      ],
      "authors": [],
      "country": "United States",
      "cpcs": [
        "G08G5/0013",
        "H04L67/12",
        "G08G5/045"
      ],
      "data_quality_score": 0.87,
      "domain": "Mobility",
      "id": "patents_MB-PAT-004",
      "inventors": [
        "Yang, Xiaoqian",
        "Kopardekar, Parimal",
        "Johnson, Marcus"
      ],
      "ipcs": [
        "G08G5/00",
        "H04L67/12",
        "G08G5/04"
      ],
      "keywords": [
        "urban air mobility",
        "eVTOL",
        "air traffic management",
        "UAM"
      ],
      "knowledge_type": "patent",
      "publication_date": "2023-01-26",
      "publishers": [],
      "related_titles": [
        "Urban Air Mobility: Infrastructure Requirements and Operational Challenges",
        "Sustainable Aviation Fuel Production from Municipal Waste",
        "AI-Enabled Traffic Signal Control System",
        "Machine Learning Approaches for Traffic Signal Control: A Comparative Analysis"
      ],
      "similarity_score": 0.6166,
      "subdomains": [
        "Urban Air Mobility",
        "Traffic Management"
      ],
      "summary_text": "No summary available",
      "technologies": [
        "urban air mobility",
        "air traffic management",
        "distributed systems"
      ],
      "title": "Urban Air Mobility Traffic Management System"
    },
    {
      "assignees": [
        "MedFly Systems"
      ],
      "authors": [],
      "country": "United States",
      "cpcs": [
        "B64C39/024",
        "G05D1/0088",
        "A61G3/00"
      ],
      "data_quality_score": 0.85,
      "domain": "Mobility",
      "id": "patents_MB-PAT-014",
      "inventors": [
        "Nguyen, Thuy",
        "Okonkwo, Chima",
        "Ramos, Isabella"
      ],
      "ipcs": [
        "B64C39/02",
        "G05D1/00",
        "A61G3/00"
      ],
      "keywords": [
        "medical delivery",
        "emergency response",
        "drone delivery",
        "healthcare logistics"
      ],
      "knowledge_type": "patent",
      "publication_date": "2022-06-16",
      "publishers": [],
      "related_titles": [],
      "similarity_score": 0.6164,
      "subdomains": [
        "Drone Technology",
        "Healthcare Logistics"
      ],
      "summary_text": "No summary available",
      "technologies": [
        "autonomous drones",
        "medical logistics",
        "remote sensing"
      ],
      "title": "Drone-Based Emergency Medical Supply Delivery System"
    }
  ],
  "response_to_user_prompt": "",
  "source": "neo4j",
  "trend_summary": "- ID: patents_BT-PAT-020 | Title: Real-Time Pathogen Detection System Using Metagenomic Sequencing | Domain: Healthcare | Knowledge Type: patent | Publication Date: 2023-05-04 | Quality Score: 0.88 | Country: United States | Score: 0.6647\n  Assignees: RapidDx Genomics\n  Inventors: Schatz, Michael C., Phillippy, Adam M., Zimin, Aleksey V.\n  Technologies: metagenomic sequencing, nanopore technology, bioinformatics\n  Subdomains: Biotech, Diagnostics\n  Keywords: metagenomic, pathogen detection, antimicrobial resistance, nanopore sequencing\n  Related_titles: Method for mRNA Delivery Using Lipid Nanoparticles, CRISPR-Cas9 System for Targeted Gene Editing, Bispecific Antibodies Targeting PD-1 and CTLA-4, Engineered CAR-T Cells with Enhanced Tumor Targeting, Microbiome-Based Therapeutics for Inflammatory Bowel Disease, Scalable Process for Manufacturing Exosome Therapeutics, Synthetic Biology Platform for On-Demand Therapeutic Protein Production, AI-Based Platform for De Novo Protein Design, Biodegradable Scaffolds for 3D Bioprinting of Functional Tissues, High-Throughput Screening Platform for Antibody Discovery, Engineered Bacterial Strains for Targeted Colorectal Cancer Therapy, RNA-Based Vaccine Platform for Infectious Diseases, Organs-on-Chips for Drug Toxicity Testing, Machine Learning Platform for Predicting Drug-Target Interactions, Nanobody Therapeutics for Neurodegenerative Diseases, Gene Therapy for Age-Related Macular Degeneration, Continuous Manufacturing Process for mRNA Vaccines, PROTAC Technology for Protein Degradation, Single-Cell Multi-omics Analysis of the Immune Response in COVID-19, CRISPR-Engineered T Cells in Patients with Refractory Cancer, Spatial Transcriptomics Reveals Insights into the Tumor Microenvironment, In Vivo Base Editing Corrects Hutchinson–Gilford Progeria Syndrome in Mice, Engineered Living Materials: Prospects and Challenges for Using Biological Systems to Direct the Assembly of Smart Materials, Intestinal Organoids as a Tool for Inflammatory Bowel Disease Research, Enzyme-Free Biosensor for Continuous Glucose Monitoring, Microbiome-Based Therapeutics Shape the Gut Microbiome and Improve Metabolic Syndrome, Massively Parallel Screening of Protein Design Space Using Machine Learning, PROTAC Degraders for Previously Undruggable Transcription Factors in Cancer\n- ID: patents_BT-PAT-012 | Title: RNA-Based Vaccine Platform for Infectious Diseases | Domain: Healthcare | Knowledge Type: patent | Publication Date: 2019-09-05 | Quality Score: 0.93 | Country: United States | Score: 0.6376\n  Assignees: RapidVax Inc.\n  Inventors: Karikó, Katalin, Weissman, Drew, Pardi, Norbert\n  Technologies: lipid nanoparticles, mRNA vaccines, infectious disease\n  Subdomains: Biotech, Vaccines\n  Keywords: mRNA, vaccine, infectious disease, lipid nanoparticle\n  Related_titles: Method for mRNA Delivery Using Lipid Nanoparticles, CRISPR-Cas9 System for Targeted Gene Editing, Bispecific Antibodies Targeting PD-1 and CTLA-4, Engineered CAR-T Cells with Enhanced Tumor Targeting, Microbiome-Based Therapeutics for Inflammatory Bowel Disease, Scalable Process for Manufacturing Exosome Therapeutics, Synthetic Biology Platform for On-Demand Therapeutic Protein Production, AI-Based Platform for De Novo Protein Design, Biodegradable Scaffolds for 3D Bioprinting of Functional Tissues, High-Throughput Screening Platform for Antibody Discovery, Engineered Bacterial Strains for Targeted Colorectal Cancer Therapy, Organs-on-Chips for Drug Toxicity Testing, Machine Learning Platform for Predicting Drug-Target Interactions, Nanobody Therapeutics for Neurodegenerative Diseases, Gene Therapy for Age-Related Macular Degeneration, Continuous Manufacturing Process for mRNA Vaccines, PROTAC Technology for Protein Degradation, Real-Time Pathogen Detection System Using Metagenomic Sequencing, Single-Cell Multi-omics Analysis of the Immune Response in COVID-19, CRISPR-Engineered T Cells in Patients with Refractory Cancer, Spatial Transcriptomics Reveals Insights into the Tumor Microenvironment, In Vivo Base Editing Corrects Hutchinson–Gilford Progeria Syndrome in Mice, Engineered Living Materials: Prospects and Challenges for Using Biological Systems to Direct the Assembly of Smart Materials, Intestinal Organoids as a Tool for Inflammatory Bowel Disease Research, Enzyme-Free Biosensor for Continuous Glucose Monitoring, Microbiome-Based Therapeutics Shape the Gut Microbiome and Improve Metabolic Syndrome, Massively Parallel Screening of Protein Design Space Using Machine Learning, PROTAC Degraders for Previously Undruggable Transcription Factors in Cancer\n- ID: journals_BT-JRN-003 | Title: Spatial Transcriptomics Reveals Insights into the Tumor Microenvironment | Domain: Healthcare | Knowledge Type: journal | Publication Date: 2022-09-15 | Quality Score: 0.92 | Country: United States | Score: 0.6326\n  Subdomains: Biotech, Oncology\n  Keywords: spatial transcriptomics, tumor microenvironment, cancer, gene expression, precision medicine\n  Related_titles: Method for mRNA Delivery Using Lipid Nanoparticles, CRISPR-Cas9 System for Targeted Gene Editing, Bispecific Antibodies Targeting PD-1 and CTLA-4, Engineered CAR-T Cells with Enhanced Tumor Targeting, Microbiome-Based Therapeutics for Inflammatory Bowel Disease, Scalable Process for Manufacturing Exosome Therapeutics, Synthetic Biology Platform for On-Demand Therapeutic Protein Production, AI-Based Platform for De Novo Protein Design, Biodegradable Scaffolds for 3D Bioprinting of Functional Tissues, High-Throughput Screening Platform for Antibody Discovery, Engineered Bacterial Strains for Targeted Colorectal Cancer Therapy, RNA-Based Vaccine Platform for Infectious Diseases, Organs-on-Chips for Drug Toxicity Testing, Machine Learning Platform for Predicting Drug-Target Interactions, Nanobody Therapeutics for Neurodegenerative Diseases, Gene Therapy for Age-Related Macular Degeneration, Continuous Manufacturing Process for mRNA Vaccines, PROTAC Technology for Protein Degradation, Real-Time Pathogen Detection System Using Metagenomic Sequencing, Single-Cell Multi-omics Analysis of the Immune Response in COVID-19, CRISPR-Engineered T Cells in Patients with Refractory Cancer, In Vivo Base Editing Corrects Hutchinson–Gilford Progeria Syndrome in Mice, Engineered Living Materials: Prospects and Challenges for Using Biological Systems to Direct the Assembly of Smart Materials, Intestinal Organoids as a Tool for Inflammatory Bowel Disease Research, Enzyme-Free Biosensor for Continuous Glucose Monitoring, Microbiome-Based Therapeutics Shape the Gut Microbiome and Improve Metabolic Syndrome, Massively Parallel Screening of Protein Design Space Using Machine Learning, PROTAC Degraders for Previously Undruggable Transcription Factors in Cancer\n- ID: patents_BT-PAT-001 | Title: Method for mRNA Delivery Using Lipid Nanoparticles | Domain: Healthcare | Knowledge Type: patent | Publication Date: 2020-05-12 | Quality Score: 0.95 | Country: United States | Score: 0.63\n  Assignees: NanoTherapeutics, Inc.\n  Inventors: Chen, Li-Qiang, Rodriguez, Maria, Patel, Amit K.\n  Technologies: mRNA, lipid nanoparticles, drug delivery\n  Subdomains: Biotech, Drug Delivery\n  Keywords: mRNA delivery, LNP, nanoparticle, gene therapy\n  Related_titles: Gene Therapy for Age-Related Macular Degeneration, In Vivo Base Editing Corrects Hutchinson–Gilford Progeria Syndrome in Mice, RNA-Based Vaccine Platform for Infectious Diseases, Continuous Manufacturing Process for mRNA Vaccines, CRISPR-Cas9 System for Targeted Gene Editing, Bispecific Antibodies Targeting PD-1 and CTLA-4, Engineered CAR-T Cells with Enhanced Tumor Targeting, Microbiome-Based Therapeutics for Inflammatory Bowel Disease, Scalable Process for Manufacturing Exosome Therapeutics, Synthetic Biology Platform for On-Demand Therapeutic Protein Production, AI-Based Platform for De Novo Protein Design, Biodegradable Scaffolds for 3D Bioprinting of Functional Tissues, High-Throughput Screening Platform for Antibody Discovery, Engineered Bacterial Strains for Targeted Colorectal Cancer Therapy, Organs-on-Chips for Drug Toxicity Testing, Machine Learning Platform for Predicting Drug-Target Interactions, Nanobody Therapeutics for Neurodegenerative Diseases, PROTAC Technology for Protein Degradation, Real-Time Pathogen Detection System Using Metagenomic Sequencing, Single-Cell Multi-omics Analysis of the Immune Response in COVID-19, CRISPR-Engineered T Cells in Patients with Refractory Cancer, Spatial Transcriptomics Reveals Insights into the Tumor Microenvironment, Engineered Living Materials: Prospects and Challenges for Using Biological Systems to Direct the Assembly of Smart Materials, Intestinal Organoids as a Tool for Inflammatory Bowel Disease Research, Enzyme-Free Biosensor for Continuous Glucose Monitoring, Microbiome-Based Therapeutics Shape the Gut Microbiome and Improve Metabolic Syndrome, Massively Parallel Screening of Protein Design Space Using Machine Learning, PROTAC Degraders for Previously Undruggable Transcription Factors in Cancer\n- ID: patents_BT-PAT-011 | Title: Engineered Bacterial Strains for Targeted Colorectal Cancer Therapy | Domain: Healthcare | Knowledge Type: patent | Publication Date: 2022-12-08 | Quality Score: 0.87 | Country: United States | Score: 0.6247\n  Assignees: BacteriaTx Inc.\n  Inventors: Danino, Tal, Leventhal, Daniel S., Zhang, Shuyi\n  Technologies: genetic engineering, synthetic biology, bacterial therapeutics\n  Subdomains: Biotech, Microbiome\n  Keywords: synthetic biology, engineered bacteria, cancer therapy, probiotic\n  Related_titles: Method for mRNA Delivery Using Lipid Nanoparticles, CRISPR-Cas9 System for Targeted Gene Editing, Bispecific Antibodies Targeting PD-1 and CTLA-4, Engineered CAR-T Cells with Enhanced Tumor Targeting, Microbiome-Based Therapeutics for Inflammatory Bowel Disease, Scalable Process for Manufacturing Exosome Therapeutics, Synthetic Biology Platform for On-Demand Therapeutic Protein Production, AI-Based Platform for De Novo Protein Design, Biodegradable Scaffolds for 3D Bioprinting of Functional Tissues, High-Throughput Screening Platform for Antibody Discovery, RNA-Based Vaccine Platform for Infectious Diseases, Organs-on-Chips for Drug Toxicity Testing, Machine Learning Platform for Predicting Drug-Target Interactions, Nanobody Therapeutics for Neurodegenerative Diseases, Gene Therapy for Age-Related Macular Degeneration, Continuous Manufacturing Process for mRNA Vaccines, PROTAC Technology for Protein Degradation, Real-Time Pathogen Detection System Using Metagenomic Sequencing, Single-Cell Multi-omics Analysis of the Immune Response in COVID-19, CRISPR-Engineered T Cells in Patients with Refractory Cancer, Spatial Transcriptomics Reveals Insights into the Tumor Microenvironment, In Vivo Base Editing Corrects Hutchinson–Gilford Progeria Syndrome in Mice, Engineered Living Materials: Prospects and Challenges for Using Biological Systems to Direct the Assembly of Smart Materials, Intestinal Organoids as a Tool for Inflammatory Bowel Disease Research, Enzyme-Free Biosensor for Continuous Glucose Monitoring, Microbiome-Based Therapeutics Shape the Gut Microbiome and Improve Metabolic Syndrome, Massively Parallel Screening of Protein Design Space Using Machine Learning, PROTAC Degraders for Previously Undruggable Transcription Factors in Cancer\n- ID: patents_BT-PAT-017 | Title: Continuous Manufacturing Process for mRNA Vaccines | Domain: Healthcare | Knowledge Type: patent | Publication Date: 2022-08-11 | Quality Score: 0.87 | Country: United States | Score: 0.6223\n  Assignees: Continuous Biologics Inc.\n  Inventors: Trout, Bernhardt L., Jensen, Klavs F., Chakravarthy, Ankur\n  Technologies: continuous manufacturing, mRNA production, process intensification\n  Subdomains: Biotech, Biologics Manufacturing\n  Keywords: biomanufacturing, continuous manufacturing, mRNA vaccine, process intensification\n  Related_titles: Method for mRNA Delivery Using Lipid Nanoparticles, CRISPR-Cas9 System for Targeted Gene Editing, Bispecific Antibodies Targeting PD-1 and CTLA-4, Engineered CAR-T Cells with Enhanced Tumor Targeting, Microbiome-Based Therapeutics for Inflammatory Bowel Disease, Scalable Process for Manufacturing Exosome Therapeutics, Synthetic Biology Platform for On-Demand Therapeutic Protein Production, AI-Based Platform for De Novo Protein Design, Biodegradable Scaffolds for 3D Bioprinting of Functional Tissues, High-Throughput Screening Platform for Antibody Discovery, Engineered Bacterial Strains for Targeted Colorectal Cancer Therapy, RNA-Based Vaccine Platform for Infectious Diseases, Organs-on-Chips for Drug Toxicity Testing, Machine Learning Platform for Predicting Drug-Target Interactions, Nanobody Therapeutics for Neurodegenerative Diseases, Gene Therapy for Age-Related Macular Degeneration, PROTAC Technology for Protein Degradation, Real-Time Pathogen Detection System Using Metagenomic Sequencing, Single-Cell Multi-omics Analysis of the Immune Response in COVID-19, CRISPR-Engineered T Cells in Patients with Refractory Cancer, Spatial Transcriptomics Reveals Insights into the Tumor Microenvironment, In Vivo Base Editing Corrects Hutchinson–Gilford Progeria Syndrome in Mice, Engineered Living Materials: Prospects and Challenges for Using Biological Systems to Direct the Assembly of Smart Materials, Intestinal Organoids as a Tool for Inflammatory Bowel Disease Research, Enzyme-Free Biosensor for Continuous Glucose Monitoring, Microbiome-Based Therapeutics Shape the Gut Microbiome and Improve Metabolic Syndrome, Massively Parallel Screening of Protein Design Space Using Machine Learning, PROTAC Degraders for Previously Undruggable Transcription Factors in Cancer\n- ID: journals_BT-JRN-010 | Title: PROTAC Degraders for Previously Undruggable Transcription Factors in Cancer | Domain: Healthcare | Knowledge Type: journal | Publication Date: 2023-04-18 | Quality Score: 0.93 | Country: United States | Score: 0.6203\n  Subdomains: Biotech, Drug Discovery\n  Keywords: cancer therapy, PROTAC, undruggable targets, transcription factors, targeted protein degradation\n  Related_titles: Method for mRNA Delivery Using Lipid Nanoparticles, CRISPR-Cas9 System for Targeted Gene Editing, Bispecific Antibodies Targeting PD-1 and CTLA-4, Engineered CAR-T Cells with Enhanced Tumor Targeting, Microbiome-Based Therapeutics for Inflammatory Bowel Disease, Scalable Process for Manufacturing Exosome Therapeutics, Synthetic Biology Platform for On-Demand Therapeutic Protein Production, AI-Based Platform for De Novo Protein Design, Biodegradable Scaffolds for 3D Bioprinting of Functional Tissues, High-Throughput Screening Platform for Antibody Discovery, Engineered Bacterial Strains for Targeted Colorectal Cancer Therapy, RNA-Based Vaccine Platform for Infectious Diseases, Organs-on-Chips for Drug Toxicity Testing, Machine Learning Platform for Predicting Drug-Target Interactions, Nanobody Therapeutics for Neurodegenerative Diseases, Gene Therapy for Age-Related Macular Degeneration, Continuous Manufacturing Process for mRNA Vaccines, PROTAC Technology for Protein Degradation, Real-Time Pathogen Detection System Using Metagenomic Sequencing, Single-Cell Multi-omics Analysis of the Immune Response in COVID-19, CRISPR-Engineered T Cells in Patients with Refractory Cancer, Spatial Transcriptomics Reveals Insights into the Tumor Microenvironment, In Vivo Base Editing Corrects Hutchinson–Gilford Progeria Syndrome in Mice, Engineered Living Materials: Prospects and Challenges for Using Biological Systems to Direct the Assembly of Smart Materials, Intestinal Organoids as a Tool for Inflammatory Bowel Disease Research, Enzyme-Free Biosensor for Continuous Glucose Monitoring, Microbiome-Based Therapeutics Shape the Gut Microbiome and Improve Metabolic Syndrome, Massively Parallel Screening of Protein Design Space Using Machine Learning\n- ID: patents_BT-PAT-015 | Title: Nanobody Therapeutics for Neurodegenerative Diseases | Domain: Healthcare | Knowledge Type: patent | Publication Date: 2021-04-08 | Quality Score: 0.86 | Country: United States | Score: 0.6187\n  Assignees: NeuroNano Therapeutics\n  Inventors: Muyldermans, Serge, Steyaert, Jan, De Genst, Erwin\n  Technologies: nanobodies, blood-brain barrier, protein targeting\n  Subdomains: Biotech, Neuroscience\n  Keywords: nanobody, neurodegenerative disease, blood-brain barrier, protein misfolding\n  Related_titles: Method for mRNA Delivery Using Lipid Nanoparticles, CRISPR-Cas9 System for Targeted Gene Editing, Bispecific Antibodies Targeting PD-1 and CTLA-4, Engineered CAR-T Cells with Enhanced Tumor Targeting, Microbiome-Based Therapeutics for Inflammatory Bowel Disease, Scalable Process for Manufacturing Exosome Therapeutics, Synthetic Biology Platform for On-Demand Therapeutic Protein Production, AI-Based Platform for De Novo Protein Design, Biodegradable Scaffolds for 3D Bioprinting of Functional Tissues, High-Throughput Screening Platform for Antibody Discovery, Engineered Bacterial Strains for Targeted Colorectal Cancer Therapy, RNA-Based Vaccine Platform for Infectious Diseases, Organs-on-Chips for Drug Toxicity Testing, Machine Learning Platform for Predicting Drug-Target Interactions, Gene Therapy for Age-Related Macular Degeneration, Continuous Manufacturing Process for mRNA Vaccines, PROTAC Technology for Protein Degradation, Real-Time Pathogen Detection System Using Metagenomic Sequencing, Single-Cell Multi-omics Analysis of the Immune Response in COVID-19, CRISPR-Engineered T Cells in Patients with Refractory Cancer, Spatial Transcriptomics Reveals Insights into the Tumor Microenvironment, In Vivo Base Editing Corrects Hutchinson–Gilford Progeria Syndrome in Mice, Engineered Living Materials: Prospects and Challenges for Using Biological Systems to Direct the Assembly of Smart Materials, Intestinal Organoids as a Tool for Inflammatory Bowel Disease Research, Enzyme-Free Biosensor for Continuous Glucose Monitoring, Microbiome-Based Therapeutics Shape the Gut Microbiome and Improve Metabolic Syndrome, Massively Parallel Screening of Protein Design Space Using Machine Learning, PROTAC Degraders for Previously Undruggable Transcription Factors in Cancer\n- ID: patents_MB-PAT-004 | Title: Urban Air Mobility Traffic Management System | Domain: Mobility | Knowledge Type: patent | Publication Date: 2023-01-26 | Quality Score: 0.87 | Country: United States | Score: 0.6166\n  Assignees: UrbanAir Systems\n  Inventors: Yang, Xiaoqian, Kopardekar, Parimal, Johnson, Marcus\n  Technologies: urban air mobility, air traffic management, distributed systems\n  Subdomains: Urban Air Mobility, Traffic Management\n  Keywords: urban air mobility, eVTOL, air traffic management, UAM\n  Related_titles: Urban Air Mobility: Infrastructure Requirements and Operational Challenges, Sustainable Aviation Fuel Production from Municipal Waste, AI-Enabled Traffic Signal Control System, Machine Learning Approaches for Traffic Signal Control: A Comparative Analysis\n- ID: patents_MB-PAT-014 | Title: Drone-Based Emergency Medical Supply Delivery System | Domain: Mobility | Knowledge Type: patent | Publication Date: 2022-06-16 | Quality Score: 0.85 | Country: United States | Score: 0.6164\n  Assignees: MedFly Systems\n  Inventors: Nguyen, Thuy, Okonkwo, Chima, Ramos, Isabella\n  Technologies: autonomous drones, medical logistics, remote sensing\n  Subdomains: Drone Technology, Healthcare Logistics\n  Keywords: medical delivery, emergency response, drone delivery, healthcare logistics\n"
}